Found 619 clinical trials
Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110)
In mid-February 2020, within the Oise (France) cluster, a case of COVID-19 disease caused by a SARS-CoV2 infection was described among the personnel of the Creail Air Force Base (BA110). This resulted in the beginning of an epidemic controlled by epidemiological measures.
- 0 views
- 19 Feb, 2024
- 1 location
Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff
COVID-19 is a pathology linked to the SARS-CoV-2 virus, a new virus of the coronaviridae family that emerged in China in December 2019 before rapidly becoming a pandemic according to the WHO on March 11, 2020.
- 0 views
- 19 Feb, 2024
- 1 location
COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses
The study is to investigate the antibody response in the blood and saliva of people with a known COVID-19 infection in the canton of Baselland.
- 0 views
- 19 Feb, 2024
- 1 location
Health Perception Practices Relations and Social Inequalities in the General Population During the Covid-19 Crisis
This study aims to quantify and follow the cumulative incidence of SARS-CoV-2 infection in the French population using serological tests and to assess the determinants of infection from Constances, E3N-E4N, ELFE-Epipage 2 and NutriNet-Sant cohorts.
- 0 views
- 19 Feb, 2024
- 1 location
COVID-19 Staff Testing of Antibody Responses Study (Co-Stars)
Within this cohort, a subset of 150-250 staff members with confirmed (PCR positive) SARS-CoV-2 disease will be followed with intensive monthly testing for 6 months to determine whether antibody levels in the blood are maintained or decrease during this time.
- 0 views
- 19 Feb, 2024
- 1 location
National Covid-19 Surveillance Physicians
The investigators will analyze the presence of antibodies against SARS-COV2 in physicians working in emergency and intensive care medicine and in those who treat Covid 19 patients.
- 0 views
- 19 Feb, 2024
- 1 location
Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV
In COVID-19 pandemic, it is of critical importance to identify a rapid and simple diagnostic method to be used in clinical settings to timely inform and refine strategies that can prevent, control, and stop the spread of SARS-CoV-2. The 2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) is a qualitative, membrane-based …
- 0 views
- 19 Feb, 2024
- 5 locations
A Longitudinal Study of COVID-19 Sequelae and Immunity
Participants in the COVID-19 group may have visits more often if they develop symptoms that suggest re-infection with SARS-CoV-2....
- 0 views
- 19 Feb, 2024
- 1 location
Detection of Anti-COVID-19 Antibody Levels in an Hospital Population
COVID-19 (SARS-CoV-2) infection in health professionals represent a significant criticality both for the risk of spreading the disease and for the organizational aspects that follow.
- 0 views
- 19 Feb, 2024
- 1 location
Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer
Expected results: The data generated will help the medical and scientific community to evaluate the increasing risk of cancer patients infected by SARS-CoV-2 compared to the non-cancer population, to identify patients at higher risk of severe infection, but also the anticancer treatments associated with an increased risk of severe infections.
- 0 views
- 19 Feb, 2024
- 5 locations